Sabina Signoretti
Sabina Signoretti
Professor, Brigham and Women's Hospital, Harvard Medical School
Verified email at
Cited by
Cited by
The landscape of somatic copy-number alteration across human cancers
R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ...
Nature 463 (7283), 899-905, 2010
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
High-throughput oncogene mutation profiling in human cancer
RK Thomas, AC Baker, RM DeBiasi, W Winckler, T LaFramboise, WM Lin, ...
Nature genetics 39 (3), 347-351, 2007
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion
AH Zea, PC Rodriguez, MB Atkins, C Hernandez, S Signoretti, J Zabaleta, ...
Cancer research 65 (8), 3044-3048, 2005
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
Essential roles of PI (3) K–p110β in cell growth, metabolism and tumorigenesis
S Jia, Z Liu, S Zhang, P Liu, L Zhang, SH Lee, J Zhang, S Signoretti, ...
Nature 454 (7205), 776-779, 2008
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
p63 is a prostate basal cell marker and is required for prostate development
S Signoretti, D Waltregny, J Dilks, B Isaac, D Lin, L Garraway, A Yang, ...
The American journal of pathology 157 (6), 1769-1775, 2000
Renal cell carcinoma
JJ Hsieh, MP Purdue, S Signoretti, C Swanton, L Albiges, M Schmidinger, ...
Nature reviews Disease primers 3, 17009, 2017
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN
N Nakamura, S Ramaswamy, F Vazquez, S Signoretti, M Loda, ...
Molecular and cellular biology 20 (23), 8969-8982, 2000
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
B Li, E Severson, JC Pignon, H Zhao, T Li, J Novak, P Jiang, H Shen, ...
Genome biology 17 (1), 1-16, 2016
The somatic genomic landscape of chromophobe renal cell carcinoma
CF Davis, CJ Ricketts, M Wang, L Yang, AD Cherniack, H Shen, C Buhay, ...
Cancer cell 26 (3), 319-330, 2014
Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets
PK Brastianos, SL Carter, S Santagata, DP Cahill, A Taylor-Weiner, ...
Cancer discovery 5 (11), 1164-1177, 2015
Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer
M Atkins, M Regan, D McDermott, J Mier, E Stanbridge, A Youmans, ...
Clinical cancer research 11 (10), 3714-3721, 2005
Her-2-neu expression and progression toward androgen independence in human prostate cancer
S Signoretti, R Montironi, J Manola, A Altimari, C Tam, G Bubley, S Balk, ...
Journal of the National Cancer Institute 92 (23), 1918-1925, 2000
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Z Ding, CJ Wu, GC Chu, Y Xiao, D Ho, J Zhang, SR Perry, ES Labrot, ...
Nature 470 (7333), 269-273, 2011
Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation
N Bardeesy, M Sinha, AF Hezel, S Signoretti, NA Hathaway, ...
Nature 419 (6903), 162-167, 2002
Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma
SP Singh, J Lipman, H Goldman, FH Ellis, L Aizenman, MG Cangi, ...
Cancer research 58 (8), 1730-1735, 1998
The system can't perform the operation now. Try again later.
Articles 1–20